Abstract
The effect of certain NO donors, viz., nitrosyl iron complexes (NICs) and their functional thio ligands, on the activity of hydrolytic enzymes was studied taking cyclic guanosine monophosphate phosphodiesterase (cGMP PDE) and sarcoplasmic reticulum (SR) Ca2+-ATPase as examples. It was shown that mononuclear dinitrosyl complexes with 4-nitrophenyl- and 5-nitropyridin-2-ylthiols as well as the binuclear tetranitrosyl complex with 3-hydroxyphenylthiol competitively inhibit the cGMP PDE action with the inhibition constants, Ki, equal to 2.3 · 10−6, 1.0 · 10−4, and 8.7 · 10−5 mol L−1, respectively, and non-competitively inhibit the function of SR Ca2+-ATPase with Ki = 7.4 · 10−5, 7.9 · 10−5 and 1.1 · 10−5 mol L−1, respectively. The thio ligands of the complexes have little effect on the enzyme activity or do not affect it at all. The results obtained make it possible to predict the antihypertensive, antiaggregatory, and vasodilatory activities of the compounds studied.
References
L. J. Ignarro, J. Physiol. Pharmacol., 2002, 53, 503.
Nitric Oxide: Principles and Actions, Ed. J. J. Lancaster, Acad. Press Inc., San Diego, 1996, 356 pp.
A. F. Vanin, Dinitrosyl Iron Complexes as a “Working Form” of Nitric Oxide in Living Organisms, Cambridge Scholars Publ., Cambridge, UK, 2019, 265 pp.
Nitrosyl Complexes in Inorganic Chemistry, Biochemistry and Medicine II, Ed. D. M. P. Mingos, Springer, Berlin—Heidelberg, 2014, 260 pp.; DOI: https://doi.org/10.1007/978-3-642-41160-1.
N. A. Sanina, S. M. Aldoshin, N. Yu. Shmatko, D. V. Korchagin, G. V. Shilov, E. V. Knyazkina, N. S. Ovanesyan, A. V. Kulikov, New J. Chem., 2015, 39, 1022; DOI: https://doi.org/10.1039/C4NJ01693A.
S. Y. Shaban, R. van Eldik, J. Coord. Chem., 2017, 70, 1713; DOI: https://doi.org/10.1080/00958972.2017.1303680.
H. Lewandowska, M. Kalinowska, K. Brzóska, K. Wójciuk, G. Wójciuk, M. Kruszewski, Dalton Trans., 2011, 40, 8273; DOI: https://doi.org/10.1039/c0dt01244k.
K. B. Shumaev, O. V. Kosmachevskaya, A. A. Timoshin, A. F. Vanin, A. F. Topunov, Methods Enzymol., 2008, 436, 445; DOI: https://doi.org/10.1016/S0076-6879(08)36025-X.
N. A. Sanina, G. I. Kozub, T. A. Kondrat’eva, D. V. Korchagin, G. V. Shilov, R. B. Morgunov, N. S. Ovanesyan, A. V. Kulikov, T. S. Stupina, A. A. Terent’ev, S. M. Aldoshin, J. Mol. Struct., 2022, 1266, 133506; DOI: https://doi.org/10.1016/j.molstruc.2022.133506.
N. A. Sanina, G. I. Kozub, O. S. Zhukova, D. V. Korchagin, T. A. Kondrat’eva, R. B. Morgunov, A. D. Talantsev, N. S. Ovanesyan, A. V. Kulikov, S. M. Aldoshin, J. Mol. Struct., 2019, 1181, 321; DOI: https://doi.org/10.1016/j.molstruc.2018.11.092.
G. I. Kozub, N. A. Sanina, N. S. Emel’yanova, A. N. Utenishev, T. A. Kondrat’eva, V. N. Khrustalev, N. S. Ovanesyan, N. E. Kupchinskaya, S. M. Aldoshin, Inorg. Chim. Acta, 2018, 480, 132; DOI: https://doi.org/10.1016/j.ica.2018.05.015.
K. Omori, J. Kotera, Circ. Res., 2007, 100, 309; DOI: https://doi.org/10.1161/01.RES.0000256354.95791.f1.
J. G. Hardman, G. A. Robison, E. W. Sutherland, Annu. Rev. Physiol., 1971, 33, 311; DOI: https://doi.org/10.1146/annurev.ph.33.030171.001523.
J. S. Padda, J. Tripp, Phosphodiesterase Inhibitors, StatPearls Publishing LLC, Treasure Island (FL), 2022.
G. S. Baillie, G. S. Tejeda, M. P. Kelly, Nat. Rev. Drug Discov., 2019, 18, 770; DOI: https://doi.org/10.1038/s41573-019-0033-4.
M. S. Miller, J. Receptor. Ligand Channel Res., 2015, 8, 19; DOI: https://doi.org/10.2147/JRLCR.S50401.
C. Jansen, A. J. Kooistra, G. K. Kanev, R. Leurs, I. J. P. de Esch, C. de Graaf, J. Med. Chem., 2016, 59, 7029; DOI: https://doi.org/10.1021/acs.jmedchem.5b01813.
J. O. Primeau, G. P. Armanious, M. E. Fisher, H. S. Young, in Membrane Protein Complexes: Structure and Function. Subcellular Biochemistry, Eds J. Harris, E. Boekema, Springer, Singapore, 2018, p. 229; DOI: https://doi.org/10.1007/978-981-10-7757-9_8.
L. Lipskaia, E. R. Chemaly, L. Hadri, A.-M. Lompre, R. J. Hajjar, Expert Opin. Biol. Ther., 2010, 10, 29; DOI: https://doi.org/10.1517/14712590903321462.
K. Rahate, L. K. Bhatt, K. S. Prabhavalkar, Chem. Biol. Drug Des., 2020, 95, 5; DOI: https://doi.org/10.1111/cbdd.13620.
J. A. Ardura, L. Álvarez-Carrión, I. Gutiérrez-Rojas, V. Alonso, Cancers, 2020, 12, 1071; DOI: https://doi.org/10.3390/cancers12051071.
S. R. Denmeade, J. T. Isaacs, Cancer Biol. Ther., 2005, 4, 21; DOI: https://doi.org/10.4161/cbt.4.1.1505.
L. Peterková, E. Kmoníčková, T. Ruml, S. Rimpelová, J. Med. Chem., 2020, 63, 1937; DOI: https://doi.org/10.1021/acs.jmedchem.9b01509.
D. Casemore, C. Xing, Integr. Cancer Sci. Ther., 2015, 2, 100; DOI: https://doi.org/10.15761/ICST.1000122.
F. Michelangeli, J. M. East, Biochem. Soc. Trans., 2011, 39, 789; DOI: https://doi.org/10.1042/BST0390789.
V. A. Mumyatova, G. I. Kozub, T. A. Kondrat’eva, A. A. Terent’ev, N. A. Sanina, Russ. Chem. Bull., 2019, 68, 1025; DOI: https://doi.org/10.1007/s11172-019-2514-3.
L. V. Tat’yanenko, A. I. Kotel’nikov, O. V. Dobrokhotova, E. A. Saratovskikh, N. A. Sanina, T. N. Rudneva, S. M. Aldoshin, Pharm. Chem. J., 2009, 43, 525; DOI: https://doi.org/10.1007/s11094-009-0346-4.
N. A. Sanina, Yu. A. Isaeva, A. N. Utenyshev, P. V. Dorovatovskii, N. S. Ovanesyan, N. S. Emel’yanova, O. V. Pokidova, L. V. Tat’yanenko, I. V. Sulimenkov, A. I. Kotel’nikov, S. M. Aldoshin, Inorg. Chim. Acta, 2021, 527, 120559; DOI: https://doi.org/10.1016/j.ica.2021.120559.
R. E. Libinzon, T. G. Shchekoldina, O. E. Batolkina, A. M. Iagniatinskaia, Voprosy meditsinskoi khimii [Problems in Med. Chem.], 1977, 23, 526 (in Russian).
V. B. Ritov, V. M. Melgunov, P. G. Komarov, O. M. Alexeeva, E. I. Akimova, Dokl. Akad. Nauk SSSR [Rep. Acad. Sci USSR], 1977, 233, 730 (in Russian).
L. V. Tatyanenko, G. N. Bogdanov, O. V. Dobrokhotova, M. A. Fadeev, B. S. Fedorov, Biochemistry (Moscow), Suppl. Ser. B: Biomed. Chem., 2007, 1, 258; DOI: https://doi.org/10.1134/S199075080703016X.
I. V. Berezin, A. A. Klesov, Prakticheskiy kurs khimicheskoy i fermentativnoy kinetiki [Chemical and Enzymatic Kinetics: A Practical Course], Izd-vo MGU, Moscow, 1976, 324 pp. (in Russian).
K.-Y. Wong, J. Gao, FEBS J., 2011, 278, 2579; DOI: https://doi.org/10.1111/j.1742-4658.2011.08187.x.
S. H. Francis, M. D. Houslay, M. Conti, in Phosphodiesterases as Drug Targets, Eds S. H. Francis, M. D. Houslay, M. Conti, Springer, Berlin, 2011, p. 47; DOI: https://doi.org/10.1007/978-3-642-17969-3_2.
Y. H. Jeon, Y.-S. Heo, C. M. Kim, Y.-L. Hyun, T. G. Lee, S. Ro, J. M. Cho, Cell. Mol. Life Sci., 2005, 62, 1198; DOI: https://doi.org/10.1007/s00018-005-4533-5.
O. V. Pokidova, V. B. Luzhkov, N. S. Emel’yanova, V. B. Krapivin, A. I. Kotelnikov, N. A. Sanina, S. M. Aldoshin, Dalton Trans., 2020, 49, 12674; DOI: https://doi.org/10.1039/D0DT02452J.
C. Toyoshima, M. Nakasako, H. Nomura, H. Ogawa, Nature, 2000, 405, 647; DOI: https://doi.org/10.1038/35015017.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was carried out within the framework of the State Assignment (Reg. No. AAAA-A19-119071890015-6).
The animal study protocols met the Institutional Animal Ethics Regulations and the Russian Federation laws and international legislation.
The authors declare no competing interests.
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, Vol. 72, No. 7, pp. 1673–1679, July, 2023.
Rights and permissions
About this article
Cite this article
Tat’yanenko, L.V., Pokidova, O.V., Goryachev, N.S. et al. Effect of nitrosyl iron complexes and their thio ligands on the activity of phosphodiesterase and sarcoplasmic reticulum Ca2+-ATPase. Russ Chem Bull 72, 1673–1679 (2023). https://doi.org/10.1007/s11172-023-3947-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-023-3947-2